ETopical – Lifestyle

Author: Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

May 14, 2026
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

May 5, 2026
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting

March 31, 2026